PD-1 Antibody Combined With COX Inhibitor in MSI-H/dMMR or High TMB Colorectal Cancer
Condition(s):Colorectal CancerLast Updated:June 29, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Colorectal CancerLast Updated:June 29, 2020Unknown status
Condition(s):Patent Ductus ArteriosusLast Updated:June 16, 2022Completed
Condition(s):TuberculosisLast Updated:April 8, 2022Completed
Condition(s):Acute Myeloid LeukemiaLast Updated:February 17, 2017Withdrawn
Condition(s):Patent Ductus ArteriosusLast Updated:April 13, 2022Completed
Condition(s):PainLast Updated:July 2, 2017Completed
Condition(s):Colorectal Cancer; Mismatch Repair-deficient (dMMR); Microsatellite Instability-high (MSI-H); Neoadjuvant TherapyLast Updated:February 28, 2023Recruiting
Condition(s):Precancerous ConditionLast Updated:August 12, 2013Completed
Condition(s):Facial PainLast Updated:March 4, 2008Completed
Condition(s):Retinal HypoxiaLast Updated:August 19, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.